Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of Pancreatic Cancer Patient–Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin
N.V. Rajeshkumar, Shinichi Yabuuchi, Shweta Pai, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 18, pp. 5639-5647
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Applications of patient-derived tumor xenograft models and tumor organoids
Go J. Yoshida
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 365
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Qin Cheng, Gang Yang, Jinshou Yang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 297
Targeting metabolism to regulate immune responses in autoimmunity and cancer
Chirag H. Patel, Robert D. Leone, Maureen R. Horton, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 9, pp. 669-688
Closed Access | Times Cited: 236
Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth
Abigail S. Krall, Peter J. Mullen, Felicia Surjono, et al.
Cell Metabolism (2021) Vol. 33, Iss. 5, pp. 1013-1026.e6
Open Access | Times Cited: 197
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Ping Jin, Jingwen Jiang, Li Zhou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 129
Precision Medicine: Disease Subtyping and Tailored Treatment
Richard Wang, Zhixiang Wang
Cancers (2023) Vol. 15, Iss. 15, pp. 3837-3837
Open Access | Times Cited: 129
Targeting OXPHOS and the electron transport chain in cancer; Molecular and therapeutic implications
John Greene, Ashvina Segaran, Simon Lord
Seminars in Cancer Biology (2022) Vol. 86, pp. 851-859
Open Access | Times Cited: 120
Targeting KRAS: from metabolic regulation to cancer treatment
Yanyan Shi, Huiling Zheng, Tianzhen Wang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 5
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability
Niklas Gremke, Pierfrancesco Polo, Aaron Dort, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 123
Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer
Rawand Masoud, Gabriela Reyes‐Castellanos, Sophie Lac, et al.
Cell Reports Medicine (2020) Vol. 1, Iss. 8, pp. 100143-100143
Open Access | Times Cited: 121
Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
Elvira Pelosi, Germana Castelli, Ugo Testa
Biomedicines (2017) Vol. 5, Iss. 4, pp. 65-65
Open Access | Times Cited: 100
Glutamine Metabolism Controls Chondrocyte Identity and Function
Steve Stegen, Gianmarco Rinaldi, Shauni Loopmans, et al.
Developmental Cell (2020) Vol. 53, Iss. 5, pp. 530-544.e8
Open Access | Times Cited: 96
The effects of metformin on gut microbiota and the immune system as research frontiers
Michaël Pollak
Diabetologia (2017) Vol. 60, Iss. 9, pp. 1662-1667
Open Access | Times Cited: 92
The biological underpinnings of therapeutic resistance in pancreatic cancer
Gregory L. Beatty, Gregor Werba, Costas A. Lyssiotis, et al.
Genes & Development (2021) Vol. 35, Iss. 13-14, pp. 940-962
Open Access | Times Cited: 88
Modeling pancreatic cancer in mice for experimental therapeutics
Kavita Mallya, Shailendra K. Gautam, Abhijit Aithal, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188554-188554
Open Access | Times Cited: 58
Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells
Christopher J. Halbrook, Galloway Thurston, Seth Boyer, et al.
Nature Cancer (2022) Vol. 3, Iss. 11, pp. 1386-1403
Open Access | Times Cited: 44
SQLE-catalyzed squalene metabolism promotes mitochondrial biogenesis and tumor development in K-ras-driven cancer
Junchen Pan, Rui Liu, Wenhua Lu, et al.
Cancer Letters (2025) Vol. 616, pp. 217586-217586
Closed Access | Times Cited: 1
Glutaminases regulate glutathione and oxidative stress in cancer
José M. Matés, José A. Campos‐Sandoval, Juan de los Santos-Jiménez, et al.
Archives of Toxicology (2020) Vol. 94, Iss. 8, pp. 2603-2623
Closed Access | Times Cited: 66
Pharmacological targeting of mitochondria in cancer stem cells: An ancient organelle at the crossroad of novel anti-cancer therapies
J. Škoda, Karolina Borankova, Patric J. Jansson, et al.
Pharmacological Research (2018) Vol. 139, pp. 298-313
Closed Access | Times Cited: 63
Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies
Gabriela Reyes‐Castellanos, Rawand Masoud, Alice Carrier
Biomedicines (2020) Vol. 8, Iss. 8, pp. 270-270
Open Access | Times Cited: 62
The ‘Achilles Heel’ of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy
Christian R. Hoerner, Viola J. Chen, Alice C. Fan
Kidney Cancer (2019) Vol. 3, Iss. 1, pp. 15-29
Open Access | Times Cited: 61
Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines
Tiziana Tataranni, Francesca Agriesti, Consiglia Pacelli, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 478-478
Open Access | Times Cited: 60
Acetyl-CoA metabolism as a therapeutic target for cancer
Guo Chen, Banghe Bao, Cheng Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115741-115741
Open Access | Times Cited: 22
Metformin-induced anticancer activities: recent insights
Stephen Safe, Vijayalekshmi Nair, Keshav Karki
Biological Chemistry (2017) Vol. 399, Iss. 4, pp. 321-335
Closed Access | Times Cited: 60
Mitochondria in cancer metabolism, an organelle whose time has come?
Rebecca G. Anderson, Lais P. Ghiraldeli, Timothy S. Pardee
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2018) Vol. 1870, Iss. 1, pp. 96-102
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top